| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |